Core Viewpoint - Ryan Specialty Holdings, Inc. will release its Third Quarter 2025 financial results on October 30, 2025, after market close [1] Financial Results Announcement - The financial results will be discussed in a conference call scheduled for 4:45 PM Eastern Time on the same day [1] - Interested parties can access the conference call through a live webcast [1]

Core Insights - Ryan Specialty reported Q2 2025 GAAP revenue of $855.2 million, exceeding analyst expectations of $832.0 million, with adjusted diluted EPS of $0.66, slightly above the consensus of $0.65 [1][2] - Organic revenue growth rate was 7.1%, down from 14.2% in Q2 2024, and below the company's guidance for FY2025 of 9.0%–11.0% [1][2] - Management lowered full-year 2025 guidance for organic revenue growth and adjusted EBITDAC margin due to ongoing softness in the property insurance market [1][9] Financial Performance - Adjusted diluted EPS increased by 13.8% year-over-year from $0.58 in Q2 2024 to $0.66 in Q2 2025 [2] - GAAP revenue rose 23.0% year-over-year from $695.4 million in Q2 2024 to $855.2 million in Q2 2025 [2] - Adjusted EBITDAC increased by 24.5% year-over-year, reflecting strong operating profitability [2] Business Overview - Ryan Specialty operates as a specialized intermediary in the excess and surplus (E&S) insurance market, providing coverage for complex or high-risk situations [3] - The company's strategy focuses on expanding its E&S market presence through organic initiatives and strategic acquisitions [4] Segment Performance - Wholesale Brokerage remained the largest revenue unit with a 7.4% year-over-year increase [6] - Binding Authorities revenue grew by 17.2%, while Underwriting Management revenue surged by 73.1% year-over-year [6] - Property-focused lines experienced a modest decline, while casualty lines grew due to increased demand in various sectors [7] Strategic Initiatives - The company emphasizes strong relationships with retail brokers and insurance carriers, investment in technology, and targeted acquisitions as key success factors [4] - Supplemental and contingent commissions rose to $35.6 million, nearly quadrupling year-over-year, supported by technology investments [8] Future Outlook - Management revised full-year organic revenue growth guidance to 9.0%–11.0% from the previous 11.0%–13.0% [9] - Adjusted EBITDAC margin expectations were tightened to 32.5%–33.0% for FY2025 [9] - The company declared a quarterly dividend of $0.12 per share, payable August 26, 2025, and will focus on organic revenue growth and integration of acquired businesses [10]

[FORM 10-Q General Information](index=1&type=section&id=FORM%2010-Q%20General%20Information) This section provides general filing information for Ryan Specialty Holdings, Inc's Q2 2025 quarterly report - The document is a Quarterly Report on Form 10-Q for Ryan Specialty Holdings, Inc, for the quarterly period ended June 30, 2025[2](index=2&type=chunk) - The registrant is a **large accelerated filer** and has filed all required reports and interactive data files[4](index=4&type=chunk) Common Stock Outstanding (July 28, 2025) | Class | Shares Outstanding | | :-------------------- | :----------------- | | Class A Common Stock | 128,039,917 | | Class B Common Stock | 135,662,599 | | **Total Common Stock** | **263,702,516** | [INDEX](index=2&type=section&id=INDEX) This section outlines the report's structure, divided into Part I (Financial Information) and Part II (Other Information) - The report is structured into two main parts: Part I Financial Information and Part II Other Information[6](index=6&type=chunk) - Part I includes Financial Statements, Management's Discussion and Analysis, Quantitative and Qualitative Disclosure About Market Risk, and Controls and Procedures[6](index=6&type=chunk) - Part II covers Legal Proceedings, Risk Factors, Unregistered Sales of Equity Securities, Defaults Upon Senior Securities, Mine Safety Disclosures, Other Information, and Exhibits[6](index=6&type=chunk) [Forward-Looking Statements](index=3&type=section&id=Forward-Looking%20Statements) This section cautions that the report contains forward-looking statements subject to substantial risks and uncertainties - The report contains forward-looking statements regarding financial condition, results of operations, plans, objectives, future performance, and business, which are subject to substantial risks and uncertainties[8](index=8&type=chunk) - Key risks include failure to recruit and retain key employees, loss of relationships with insurance carriers or clients, errors in underwriting models, damage to brand/reputation, and challenges in integrating acquired businesses[9](index=9&type=chunk) - Other significant risks involve market cyclicality, reduced insurer capacity, international operational risks (including exchange rate fluctuations), changes in interest rates, competitive pressures, and the impact of evolving technologies like artificial intelligence[9](index=9&type=chunk)[15](index=15&type=chunk) [Commonly Used Defined Terms](index=4&type=section&id=Commonly%20Used%20Defined%20Terms) This section defines key corporate, financial, and industry-specific terms used throughout the report - The section defines key terms such as 'we,' 'us,' 'our,' and 'Company' as referring to Ryan Specialty Holdings, Inc and its subsidiaries[16](index=16&type=chunk) - It clarifies financial instruments like '2030 Senior Secured Notes,' '2032 Senior Secured Notes,' 'Credit Agreement,' 'Credit Facility,' 'Revolving Credit Facility,' and 'Term Loan'[16](index=16&type=chunk)[17](index=17&type=chunk) - Industry-specific terms like 'Admitted,' 'Binding Authority,' 'E&S' (Excess and surplus lines), 'MGA' (Managing general agent), 'MGU' (Managing general underwriter), 'Specialty,' and 'Wholesale Brokerage' are also defined[17](index=17&type=chunk)[18](index=18&type=chunk) [PART I. FINANCIAL INFORMATION](index=6&type=section&id=PART%20I.%20FINANCIAL%20INFORMATION) This part presents the unaudited financial statements and management's analysis of the company's financial performance and condition [ITEM 1. FINANCIAL STATEMENTS](index=6&type=section&id=ITEM%201.%20FINANCIAL%20STATEMENTS) This item includes the Company's unaudited consolidated financial statements and accompanying notes, providing a comprehensive view of its financial position and performance [Consolidated Statements of Income (Unaudited)](index=6&type=section&id=Consolidated%20Statements%20of%20Income%20(Unaudited)) This statement details the company's revenues, expenses, and net income for the three and six-month periods ended June 30, 2025 Consolidated Statements of Income (Unaudited) - Key Metrics | Metric (in thousands) | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2024 | Change ($) | Change (%) | | :---------------------- | :------------------------------- | :------------------------------- | :--------- | :--------- | | Total Revenue | $855,170 | $695,441 | $159,729 | 23.0% | | Net Commissions and Fees | $840,857 | $680,248 | $160,609 | 23.6% | | Total Operating Expenses | $664,118 | $531,073 | $133,045 | 25.1% | | Operating Income | $191,052 | $164,368 | $26,684 | 16.2% | | Net Income | $124,705 | $118,038 | $6,667 | 5.6% | | Net Income Attributable to Ryan Specialty Holdings, Inc | $51,976 | $46,787 | $5,189 | 11.1% | | Basic EPS | $0.41 | $0.38 | $0.03 | 7.9% | | Diluted EPS | $0.38 | $0.37 | $0.01 | 2.7% | Consolidated Statements of Income (Unaudited) - Key Metrics (Six Months) | Metric (in thousands) | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | Change ($) | Change (%) | | :---------------------- | :----------------------------- | :----------------------------- | :--------- | :--------- | | Total Revenue | $1,545,336 | $1,247,487 | $297,849 | 23.9% | | Net Commissions and Fees | $1,516,985 | $1,218,135 | $298,850 | 24.5% | | Total Operating Expenses | $1,254,049 | $1,010,470 | $243,579 | 24.1% | | Operating Income | $291,287 | $237,017 | $54,270 | 22.9% | | Net Income | $120,316 | $158,715 | $(38,399) | (24.2)% | | Net Income Attributable to Ryan Specialty Holdings, Inc | $24,334 | $63,322 | $(38,988) | (61.6)% | | Basic EPS | $0.19 | $0.52 | $(0.33) | (63.5)% | | Diluted EPS | $0.18 | $0.49 | $(0.31) | (63.3)% | - Interest expense, net significantly increased by **87.4%** for the three months and **86.4%** for the six months ended June 30, 2025, primarily due to increased debt from recent acquisition activity[21](index=21&type=chunk) [Consolidated Statements of Comprehensive Income (Unaudited)](index=7&type=section&id=Consolidated%20Statements%20of%20Comprehensive%20Income%20(Unaudited)) This statement presents net income and other comprehensive income items, such as foreign currency translation adjustments Consolidated Statements of Comprehensive Income (Unaudited) - Key Metrics | Metric (in thousands) | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2024 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :---------------------- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Net Income | $124,705 | $118,038 | $120,316 | $158,715 | | Total Other Comprehensive Income (Loss), net of tax | $10,883 | $(193) | $17,151 | $2,827 | | Comprehensive Income Attributable to Ryan Specialty Holdings, Inc | $62,859 | $46,594 | $41,485 | $66,149 | - Foreign currency translation adjustments contributed significantly to other comprehensive income, with a gain of **$10,436 thousand** for the three months and **$18,917 thousand** for the six months ended June 30, 2025[23](index=23&type=chunk) [Consolidated Balance Sheets (Unaudited)](index=8&type=section&id=Consolidated%20Balance%20Sheets%20(Unaudited)) This statement provides a snapshot of the company's assets, liabilities, and stockholders' equity as of June 30, 2025 Consolidated Balance Sheets (Unaudited) - Key Metrics | Metric (in thousands) | June 30, 2025 | December 31, 2024 | Change ($) | Change (%) | | :---------------------- | :------------ | :---------------- | :--------- | :--------- | | Total Assets | $10,625,772 | $9,649,918 | $975,854 | 10.1% | | Total Liabilities | $9,443,623 | $8,551,633 | $891,990 | 10.4% | | Total Stockholders' Equity | $1,182,149 | $1,098,285 | $83,864 | 7.6% | - Current assets increased by **$477,485 thousand**, primarily driven by an increase in fiduciary cash and receivables from **$3,739,727 thousand** to **$4,474,847 thousand**[25](index=25&type=chunk) - Non-current assets increased by **$498,369 thousand**, largely due to increases in Goodwill (**$438,506 thousand**) and Customer relationships (**$141,906 thousand**), reflecting recent acquisitions[25](index=25&type=chunk) [Consolidated Statements of Cash Flows (Unaudited)](index=8&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows%20(Unaudited)) This statement details the cash inflows and outflows from operating, investing, and financing activities for the six-month period Consolidated Statements of Cash Flows (Unaudited) - Key Metrics (Six Months) | Metric (in thousands) | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | Change ($) | | :---------------------- | :----------------------------- | :----------------------------- | :--------- | | Cash Flows From Operating Activities | $210,760 | $154,288 | $56,472 | | Cash Flows From Investing Activities | $(618,980) | $(236,698) | $(382,282) | | Cash Flows From Financing Activities | $234,370 | $72,191 | $162,179 | | Net Change in Cash, Cash Equivalents, and Fiduciary Capacity | $(162,043) | $(12,229) | $(149,814) | - Cash used in investing activities significantly increased due to **$565,133 thousand** for business combinations in 2025, compared to **$214,093 thousand** in 2024[27](index=27&type=chunk) - Cash flows from financing activities were positively impacted by **$187,748 thousand** net borrowings on the Revolving Credit Facility and a **$166,304 thousand** net change in fiduciary liabilities in 2025[28](index=28&type=chunk) [Consolidated Statements of Stockholders' Equity (Unaudited)](index=9&type=section&id=Consolidated%20Statements%20of%20Stockholders'%20Equity%20(Unaudited)) This statement shows the changes in stockholders' equity, including net income, dividends, and equity-based compensation Consolidated Statements of Stockholders' Equity (Unaudited) - Key Changes (Six Months Ended June 30, 2025) | Item (in thousands) | Amount | | :-------------------- | :----- | | Net income | $124,705 | | Class A common stock dividends and Dividend Equivalents paid | $(15,962) | | Distributions and Declared Distributions to non-controlling LLC Unitholders | $(6,907) | | Foreign currency translation adjustments | $27,783 | | Equity-based compensation | $19,925 | - Total stockholders' equity increased from **$1,098,285 thousand** at December 31, 2024, to **$1,182,149 thousand** at June 30, 2025[30](index=30&type=chunk) - Non-controlling interests increased from **$470,623 thousand** at December 31, 2024, to **$572,063 thousand** at June 30, 2025[30](index=30&type=chunk) [Notes to the Consolidated Financial Statements (Unaudited)](index=10&type=section&id=Notes%20to%20the%20Consolidated%20Financial%20Statements%20(Unaudited)) These notes provide detailed explanations and supplemental information for the consolidated financial statements [1. Basis of Presentation](index=10&type=section&id=1.%20Basis%20of%20Presentation) This note describes the Company's nature of operations, its organizational structure, and the basis for preparing the unaudited interim financial statements - Ryan Specialty Holdings, Inc is a service provider of specialty products and solutions for insurance brokers, agents, and carriers, primarily acting as a wholesale broker and managing underwriter[34](index=34&type=chunk) - The Company consolidates Ryan Specialty, LLC (LLC) as a Variable Interest Entity (VIE) because it is the primary beneficiary, owning **48.4%** of outstanding LLC Common Units as of June 30, 2025[36](index=36&type=chunk)[40](index=40&type=chunk) - No material changes occurred in the Company's significant accounting policies from those disclosed in the 2024 Annual Report on Form 10-K[44](index=44&type=chunk) [2. Revenue from Contracts with Customers](index=11&type=section&id=2.%20Revenue%20from%20Contracts%20with%20Customers) This note disaggregates revenue by its three Specialties, showing significant growth across all segments, particularly in Underwriting Management Revenue from Contracts with Customers by Specialty (in thousands) | Specialty | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2024 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :-------------------- | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | Wholesale Brokerage | $477,165 | $444,129 | $837,953 | $767,574 | | Binding Authority | $94,524 | $80,630 | $196,474 | $169,265 | | Underwriting Management | $269,168 | $155,489 | $482,558 | $281,296 | | **Total Net commissions and fees** | **$840,857** | **$680,248** | **$1,516,985** | **$1,218,135** | - Underwriting Management experienced the highest growth, increasing by **73.1%** for the three months and **71.5%** for the six months ended June 30, 2025[47](index=47&type=chunk) - Contract assets, primarily from supplemental and contingent commission arrangements, increased to **$41.3 million** as of June 30, 2025, from **$35.6 million** at December 31, 2024[48](index=48&type=chunk) [3. Mergers and Acquisitions](index=11&type=section&id=3.%20Mergers%20and%20Acquisitions) This note details the Company's acquisition activities in 2025 and 2024, including purchase prices and acquired assets - In 2025, the Company acquired Velocity Risk Underwriters, LLC (**$548.6 million cash**), USQRisk Holdings, LLC (**$28.7 million cash**), and 360° Underwriting (**$28.2 million cash**), along with contingent consideration for each[49](index=49&type=chunk)[50](index=50&type=chunk)[51](index=51&type=chunk) Estimated Fair Value of Aggregate Assets and Liabilities Acquired (Six Months Ended June 30, 2025, in thousands) | Item | Amount | | :-------------------- | :--------- | | Total assets acquired | $838,825 | | Goodwill | $401,087 | | Customer relationships | $247,803 | | Total liabilities assumed | $189,273 | | Net assets acquired | $649,552 | - Acquisition-related expenses for 2025 acquisitions totaled **$9.5 million** for the six months ended June 30, 2025, recognized in General and administrative expense[54](index=54&type=chunk) [4. Receivables and Other Current Assets](index=13&type=section&id=4.%20Receivables%20and%20Other%20Current%20Assets) This note provides details on commissions and fees receivable, net of an allowance for credit losses, and other current assets Commissions and Fees Receivable – net (in thousands) | Date | Amount | | :------------ | :--------- | | June 30, 2025 | $528,561 | | Dec 31, 2024 | $389,758 | Allowance for Expected Credit Losses (in thousands) | Period (Six Months Ended June 30) | 2025 | 2024 | | :-------------------------------- | :-------- | :-------- | | Beginning of period | $3,018 | $2,458 | | Write-offs | $(2,211) | $(1,285) | | Increase in provision | $2,899 | $1,980 | | End of period | $3,706 | $3,153 | Other Current Assets (in thousands) | Item | June 30, 2025 | December 31, 2024 | | :-------------------- | :------------ | :---------------- | | Prepaid expenses | $46,317 | $51,701 | | Insurance recoverable | $975 | $20,155 | | Interest rate cap | $7,013 | $13,936 | | Other current receivables | $26,389 | $24,159 | | **Total Other current assets** | **$80,694** | **$109,951** | [5. Leases](index=13&type=section&id=5.%20Leases) This note outlines the Company's operating lease commitments, primarily for office space, with terms extending through September 2038 Lease Costs (in thousands) | Item (Six Months Ended June 30) | 2025 | 2024 | | :------------------------------ | :-------- | :-------- | | Operating lease costs | $16,860 | $15,739 | | Short-term lease costs | $1,054 | $447 | | Sublease income | $(265) | $(296) | | **Lease costs – net** | **$17,649** | **$15,890** | - Cash paid for operating leases was **$16,876 thousand** for the six months ended June 30, 2025, compared to **$14,651 thousand** in the prior year[71](index=71&type=chunk) - The weighted average remaining lease term for operating leases was **7.2 years** as of June 30, 2025, with a weighted average discount rate of **5.4%**[71](index=71&type=chunk) [6. Debt](index=14&type=section&id=6.%20Debt) This note provides a detailed summary of the Company's outstanding debt, including term loans, senior secured notes, and revolving credit facilities Outstanding Debt (in thousands) | Debt Type | June 30, 2025 | December 31, 2024 | | :-------------------- | :------------ | :---------------- | | Term debt | $1,666,100 | $1,672,532 | | 2030 Senior Secured Notes | $402,171 | $401,676 | | 2032 Senior Secured Notes | $1,208,727 | $1,198,183 | | Revolving debt | $185,464 | $1,207 | | Premium financing notes | $6,216 | $5,863 | | Units subject to mandatory redemption | $3,399 | $3,399 | | **Total debt** | **$3,472,077**| **$3,282,860** | - The Term Loan principal increased from **$1,650.0 million** to **$1,700.0 million** in September 2024, with **$1,691.5 million** outstanding as of June 30, 2025[73](index=73&type=chunk) - The Revolving Credit Facility had a borrowing capacity of **$1,400.0 million**, with **$184.1 million** drawn as of June 30, 2025[74](index=74&type=chunk) [7. Stockholders' Equity](index=15&type=section&id=7.%20Stockholders'%20Equity) This note details the Company's authorized and outstanding stock, dividend declarations, and non-controlling interests in the LLC - The Company's certificate of incorporation authorizes **1,000,000,000 shares** of Class A common stock, **1,000,000,000 shares** of Class B common stock, and **500,000,000 shares** of preferred stock[79](index=79&type=chunk) - Class A common stock has one vote per share, while Class B common stock has **10 votes per share** but no dividend or liquidation rights[81](index=81&type=chunk) - The Company declared a regular quarterly cash dividend of **$0.12 per share** on Class A common stock for the three months ended June 30, 2025, with **$30.2 million** paid during the six months ended June 30, 2025[87](index=87&type=chunk) - As of June 30, 2025, the Company owned **48.4%** of the economic interests in the LLC, with non-controlling interests holding the remaining **51.6%**[88](index=88&type=chunk) [8. Equity-Based Compensation](index=16&type=section&id=8.%20Equity-Based%20Compensation) This note details the Company's equity-based compensation plans, including various award types, vesting schedules, and unrecognized expense - The Ryan Specialty Holdings, Inc, 2021 Omnibus Incentive Plan governs various equity-based awards, including stock options, RSUs, performance awards, and LLC equity awards[91](index=91&type=chunk) - Awards include Restricted Stock, Restricted Common Units, Restricted Stock Units (RSUs), Stock Options, Restricted LLC Units (RLUs), Class C Incentive Units (profits interests), and Performance Stock Units (PSUs) and Performance LLC Units (PLUs)[95](index=95&type=chunk)[97](index=97&type=chunk)[101](index=101&type=chunk)[105](index=105&type=chunk)[109](index=109&type=chunk)[112](index=112&type=chunk) Unrecognized Equity-Based Compensation Expense (as of June 30, 2025, in thousands) | Award Type | Amount | Weighted Average Remaining Expense Period (Years) | | :-------------------------- | :-------- | :------------------------------------------------ | | Restricted Stock | $236 | 0.2 | | IPO RSUs | $21,830 | 4.0 | | Incentive RSUs | $70,553 | 3.0 | | Reload Options | $473 | 0.7 | | Incentive Options | $271 | 1.4 | | PSUs | $42,227 | 4.7 | | Restricted Common Units | $136 | 0.2 | | IPO RLUs | $14,365 | 4.5 | | Incentive RLUs | $15,402 | 2.7 | | Reload Class C Incentive Units | $306 | 1.0 | | Staking Class C Incentive Units | $7,536 | 4.2 | | Class C Incentive Units | $4,408 | 3.3 | | PLUs | $8,612 | 3.5 | | **Total** | **$186,355**| | [9. Earnings Per Share](index=20&type=section&id=9.%20Earnings%20Per%20Share) This note provides the calculation of basic and diluted earnings per share for Class A common stock Net Income Attributable to Ryan Specialty Holdings, Inc. (in thousands) | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :-------- | :-------- | | Three Months | $51,976 | $46,787 | | Six Months | $24,334 | $63,322 | Earnings Per Share of Class A Common Stock | Period (Ended June 30) | Basic 2025 | Basic 2024 | Diluted 2025 | Diluted 2024 | | :--------------------- | :--------- | :--------- | :----------- | :----------- | | Three Months | $0.41 | $0.38 | $0.38 | $0.37 | | Six Months | $0.19 | $0.52 | $0.18 | $0.49 | - Diluted EPS calculation includes the effect of potentially dilutive shares, such as LLC equity awards and non-controlling interests' LLC Common Units exchangeable into Class A common stock[122](index=122&type=chunk) [10. Derivatives](index=21&type=section&id=10.%20Derivatives) This note describes the Company's derivative instruments used for risk management, specifically an interest rate cap - The Company previously used a deal-contingent foreign currency forward to manage GBP appreciation risk for the Castel acquisition, which was executed and recognized losses through earnings in 2024[125](index=125&type=chunk)[128](index=128&type=chunk) - An interest rate cap with a **$1,000.0 million** notional amount and **2.75%** strike, terminating December 31, 2025, is designated as a cash flow hedge to manage Term Loan interest rate exposure[126](index=126&type=chunk) - The Company expects **$7.0 million** of unrealized gains from the interest rate cap to be reclassified into earnings over the next six months[127](index=127&type=chunk) [11. Variable Interest Entities](index=22&type=section&id=11.%20Variable%20Interest%20Entities) This note clarifies that Ryan Specialty Holdings, Inc consolidates Ryan Specialty, LLC (LLC) as a Variable Interest Entity (VIE) - The Company consolidates the LLC as a Variable Interest Entity (VIE) under ASC 810, as it is the primary beneficiary with power to direct activities and absorb losses/benefits[130](index=130&type=chunk) - The Company's financial position, performance, and cash flows effectively represent those of the LLC, with specific exceptions for certain assets and liabilities attributable solely to Ryan Specialty Holdings, Inc[130](index=130&type=chunk) [12. Fair Value Measurements](index=22&type=section&id=12.%20Fair%20Value%20Measurements) This note describes the Company's fair value measurements, categorizing financial assets and liabilities into a three-tier hierarchy - Fair value measurements are categorized into a three-tier hierarchy: Level 1 (quoted prices in active markets), Level 2 (observable inputs other than Level 1), and Level 3 (unobservable inputs)[131](index=131&type=chunk) - The fair value of the interest rate cap is determined using **Level 2** inputs, while contingent consideration and contingently returnable consideration are **Level 3** fair value measurements[135](index=135&type=chunk)[136](index=136&type=chunk) Assets and Liabilities Measured at Fair Value (June 30, 2025, in thousands) | Item | Level 1 | Level 2 | Level 3 | | :------------------------ | :------ | :------ | :-------- | | Assets: Interest rate cap | $— | $7,013 | $— | | Assets: Contingently returnable consideration | $— | $— | $5,340 | | Liabilities: Contingent consideration | $— | $— | $114,627 | [13. Commitments and Contingencies](index=23&type=section&id=13.%20Commitments%20and%20Contingencies) This note addresses the Company's legal and operational commitments, primarily focusing on Errors and Omissions (E&O) exposure - The Company faces ordinary course Errors and Omissions (E&O) exposure and maintains E&O insurance with aggregate coverage of **$150.0 million** in excess of a **$5.0 million** per claim retention[141](index=141&type=chunk)[142](index=142&type=chunk) - Loss contingencies for outstanding E&O matters were **$7.2 million** as of June 30, 2025, up from **$4.9 million** at December 31, 2024[142](index=142&type=chunk) - For a specific policy misplacement issue, the Company collected **$21.1 million** from E&O insurance carriers during the six months ended June 30, 2025, and recorded a loss recovery of **$1.0 million** as of June 30, 2025[144](index=144&type=chunk) [14. Related Parties](index=24&type=section&id=14.%20Related%20Parties) This note discloses the Company's relationships and transactions with related parties, including Ryan Investment Holdings, LLC and Geneva Re, Ltd - The Company holds a **47%** interest in Ryan Investment Holdings, LLC (RIH), which is a related party variable interest entity but not consolidated[147](index=147&type=chunk) - The Company has service agreements with Geneva Re, Ltd, earning **$0.8 million** in revenue for services provided by Ryan Re and incurring **$5.4 million** in expense for subcontracted services for the six months ended June 30, 2025[150](index=150&type=chunk)[152](index=152&type=chunk) - The Company recognized **$0.2 million** in expense for business usage of aircraft from Executive Jet Management for the six months ended June 30, 2025, where Mr Ryan indirectly owns aircraft leased to EJM[153](index=153&type=chunk) [15. Income Taxes](index=25&type=section&id=15.%20Income%20Taxes) This note explains the Company's income tax structure, effective tax rates, and Tax Receivable Agreement (TRA) liabilities Effective Tax Rate | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :---- | :---- | | Three Months | 9.60% | 13.70%| | Six Months | 36.30%| 13.70%| - The effective tax rate for the six months ended June 30, 2025, was higher primarily due to a **$48.0 million** non-cash deferred income tax expense from the Common Control Reorganization (CCR) related to the Velocity acquisition[155](index=155&type=chunk)[158](index=158&type=chunk) Tax Receivable Agreement (TRA) Liabilities (in thousands) | Item | June 30, 2025 | December 31, 2024 | | :-------------------- | :------------ | :---------------- | | TRA Liabilities | $461,112 | $436,296 | | Exchange Tax Attributes | $271,094 | $253,233 | | Pre-IPO M&A Tax Attributes | $84,591 | $83,415 | | TRA Payment Tax Attributes | $105,427 | $99,648 | [16. Accumulated Other Comprehensive Income (Loss)](index=26&type=section&id=16.%20Accumulated%20Other%20Comprehensive%20Income%20(Loss)) This note reconciles the changes in Accumulated Other Comprehensive Income (Loss) (AOCI), net of tax Accumulated Other Comprehensive Income (Loss) (in thousands) | Item (as of) | June 30, 2025 | December 31, 2024 | | :-------------------- | :------------ | :---------------- | | Balance | $15,355 | $(1,796) | | Foreign Currency Translation Adjustments | $15,907 | $(3,010) | | Gain on Interest Rate Cap | $208 | $1,435 | - Foreign currency translation adjustments significantly contributed to the increase in AOCI, with **$18,632 thousand** before reclassifications for the six months ended June 30, 2025[164](index=164&type=chunk) [17. Segment Reporting](index=26&type=section&id=17.%20Segment%20Reporting) This note states that Ryan Specialty operates as a single operating and reporting segment and provides a geographic breakdown of revenue - Ryan Specialty is organized as a single operating and reporting segment, with its Chief Executive Officer serving as the chief operating decision maker (CODM)[165](index=165&type=chunk) - The CODM utilizes consolidated net income as the primary metric to monitor budget versus actual results, assess business performance, and make resource allocation decisions[166](index=166&type=chunk) Geographic Revenue (in thousands) | Region | Three Months Ended June 30, 2025 | Three Months Ended June 30, 2024 | Six Months Ended June 30, 2025 | Six Months Ended June 30, 2024 | | :------------ | :------------------------------- | :------------------------------- | :----------------------------- | :----------------------------- | | United States | $801,491 | $664,541 | $1,450,588 | $1,201,706 | | Foreign | $53,679 | $30,900 | $94,748 | $45,781 | | **Total revenue** | **$855,170** | **$695,441** | **$1,545,336** | **$1,247,487** | [18. Supplemental Financial Information](index=27&type=section&id=18.%20Supplemental%20Financial%20Information) This note provides supplemental details on cash paid for interest and taxes, and non-cash investing and financing activities Cash Paid for (Six Months Ended June 30, in thousands) | Item | 2025 | 2024 | | :-------------------- | :------- | :------- | | Interest, net | $95,414 | $62,153 | | Income taxes, net of refunds | $6,371 | $10,523 | Non-Cash Investing and Financing Activities (Six Months Ended June 30, 2025, in thousands) | Item | Amount | | :---------------------------------------- | :------- | | Tax Receivable Agreement liabilities | $24,460 | | Contingent consideration liabilities | $44,091 | - On May 1, 2025, the Company acquired a **9.9%** interest in Velocity Specialty Insurance Company (VSIC) for **$16.6 million**, accounted for under the equity method[172](index=172&type=chunk)[173](index=173&type=chunk) [19. Subsequent Events](index=28&type=section&id=19.%20Subsequent%20Events) This note discloses events that occurred after the reporting period, including an acquisition and a dividend approval - On July 1, 2025, the Company acquired certain assets of J.M Wilson Corporation, an MGA and surplus lines broker, for approximately **$70.0 million cash** and **$20.0 million LLC Common Units**[175](index=175&type=chunk) - On July 31, 2025, the Board of Directors approved a quarterly cash dividend of **$0.12 per share** of outstanding Class A common stock, payable on August 26, 2025[176](index=176&type=chunk) [ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS](index=28&type=section&id=ITEM%202.%20MANAGEMENT'S%20DISCUSSION%20AND%20ANALYSIS%20OF%20FINANCIAL%20CONDITION%20AND%20RESULTS%20OF%20OPERATIONS) This section provides management's perspective on the Company's financial condition, results of operations, liquidity, and cash flows [Overview](index=28&type=section&id=Overview) This overview describes Ryan Specialty Holdings, Inc as a service provider of specialty insurance products and solutions in the Excess & Surplus (E&S) market - Ryan Specialty is a service provider of specialty products and solutions for insurance brokers, agents, and carriers, founded in 2010[179](index=179&type=chunk) - The Company primarily operates as a wholesale broker and a managing underwriter or program administrator with delegated authority from insurance carriers[179](index=179&type=chunk) - A significant majority of premiums are placed in the E&S market, which offers more flexibility for complex risks[180](index=180&type=chunk) [Significant Events and Transactions](index=28&type=section&id=Significant%20Events%20and%20Transactions) This section highlights the Company's corporate structure and details recent acquisition activities in 2025 - The Company is a holding company that operates and controls the business of Ryan Specialty, LLC (LLC) through New LLC, consolidating its financial results[182](index=182&type=chunk) - Recent 2025 acquisitions include Velocity Risk Underwriters, LLC (February 3), USQRisk Holdings, LLC (May 1), and 360° Underwriting (May 16)[183](index=183&type=chunk)[184](index=184&type=chunk) - Subsequent to the reporting period, on July 1, 2025, the Company acquired certain assets of J.M Wilson Corporation[184](index=184&type=chunk) [Key Factors Affecting Our Performance](index=29&type=section&id=Key%20Factors%20Affecting%20Our%20Performance) This section outlines the critical drivers of the Company's financial performance, including acquisitions, relationships, and market conditions - The Company's performance is driven by pursuing strategic acquisitions, deepening relationships with retail broker trading partners, and building its Delegated Authority business[186](index=186&type=chunk)[187](index=187&type=chunk)[188](index=188&type=chunk) - Other key factors include investing in operations and growth, generating commissions regardless of E&S market conditions, and managing changing macroeconomic conditions[189](index=189&type=chunk)[190](index=190&type=chunk)[191](index=191&type=chunk) - The Company leverages the growth of the E&S market, driven by complex risks, but acknowledges that market dynamics can shift[192](index=192&type=chunk)[193](index=193&type=chunk)[194](index=194&type=chunk) [Components of Results of Operations](index=30&type=section&id=Components%20of%20Results%20of%20Operations) This section defines the key revenue and expense components that make up the Company's results of operations - Revenue is primarily derived from Net Commissions and Fees across Wholesale Brokerage, Binding Authority, and Underwriting Management Specialties, and Fiduciary Investment Income[196](index=196&type=chunk)[201](index=201&type=chunk) - Key expenses include Compensation and Benefits (largest expense), General and Administrative, Amortization (primarily from acquired intangible assets), and Interest Expense, Net[202](index=202&type=chunk)[203](index=203&type=chunk)[204](index=204&type=chunk)[205](index=205&type=chunk) - Income Tax Expense includes taxes on the Company's allocable share of LLC's taxable income and impacts from the Common Control Reorganization (CCR)[207](index=207&type=chunk) [Results of Operations](index=31&type=section&id=Results%20of%20Operations) This section provides a detailed comparison of the company's operational results for the three and six-month periods [Comparison of the Three Months Ended June 30, 2025 and 2024](index=31&type=section&id=Comparison%20of%20the%20Three%20Months%20Ended%20June%2030%2C%202025%20and%202024) For Q2 2025, total revenue increased by 23.0% year-over-year, driven by strong growth across all Specialties, while net income increased by 5.6% - Total revenue increased by **$159.7 million**, or **23.0%**, to **$855.2 million**, driven by a **$160.6 million** increase in Net commissions and fees[210](index=210&type=chunk)[214](index=214&type=chunk) Net Commissions and Fees Growth by Specialty (Three Months Ended June 30) | Specialty | 2025 (in thousands) | 2024 (in thousands) | Change ($) | Change (%) | | :-------------------- | :------------------ | :------------------ | :--------- | :--------- | | Wholesale Brokerage | $477,165 | $444,129 | $33,036 | 7.4% | | Binding Authority | $94,524 | $80,630 | $13,894 | 17.2% | | Underwriting Management | $269,168 | $155,489 | $113,679 | 73.1% | - Net income increased by **$6.7 million**, or **5.6%**, to **$124.7 million**, despite a significant increase in interest expense, net (**$27.2 million**, or **87.4%**)[210](index=210&type=chunk)[229](index=229&type=chunk)[233](index=233&type=chunk) [Comparison of the Six Months Ended June 30, 2025 and 2024](index=34&type=section&id=Comparison%20of%20the%20Six%20Months%20Ended%20June%2030%2C%202025%20and%202024) For H1 2025, total revenue increased by 23.9% year-over-year, but net income decreased by 24.2% due to a substantial increase in income tax expense - Total revenue increased by **$297.8 million**, or **23.9%**, to **$1,545.3 million**, driven by a **$298.8 million** increase in Net commissions and fees[210](index=210&type=chunk)[235](index=235&type=chunk) Net Commissions and Fees Growth by Specialty (Six Months Ended June 30) | Specialty | 2025 (in thousands) | 2024 (in thousands) | Change ($) | Change (%) | | :-------------------- | :------------------ | :------------------ | :--------- | :--------- | | Wholesale Brokerage | $837,953 | $767,574 | $70,379 | 9.2% | | Binding Authority | $196,474 | $169,265 | $27,209 | 16.1% | | Underwriting Management | $482,558 | $281,296 | $201,262 | 71.5% | - Net income decreased by **$38.4 million**, or **24.2%**, to **$120.3 million**, primarily due to a **$43.3 million** increase in income tax expense from the Common Control Reorganization[210](index=210&type=chunk)[249](index=249&type=chunk)[250](index=250&type=chunk) [Non-GAAP Financial Measures and Key Performance Indicators](index=36&type=section&id=Non-GAAP%20Financial%20Measures%20and%20Key%20Performance%20Indicators) This section defines and reconciles various non-GAAP financial measures used by management to assess operating performance [Organic Revenue Growth Rate](index=36&type=section&id=Organic%20Revenue%20Growth%20Rate) The Organic Revenue Growth Rate, a non-GAAP measure, was 7.1% for Q2 2025 and 9.6% for H1 2025 - Organic Revenue Growth Rate is defined as the percentage change in Net commissions and fees, adjusted for revenue attributable to acquisitions, sold businesses, contingent commissions, and foreign exchange rates[254](index=254&type=chunk) Organic Revenue Growth Rate (Non-GAAP) | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :---- | :---- | | Three Months | 7.1% | 14.2% | | Six Months | 9.6% | 14.0% | [Adjusted Compensation and Benefits Expense and Adjusted Compensation and Benefits Expense Ratio](index=36&type=section&id=Adjusted%20Compensation%20and%20Benefits%20Expense%20and%20Adjusted%20Compensation%20and%20Benefits%20Expense%20Ratio) Adjusted compensation and benefits expense increased, while the adjusted ratio decreased, indicating improved efficiency relative to total revenue - Adjusted compensation and benefits expense excludes equity-based compensation, acquisition and restructuring related compensation expense, and other exceptional items[256](index=256&type=chunk) Adjusted Compensation and Benefits Expense (in thousands) | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :-------- | :-------- | | Three Months | $453,414 | $383,960 | | Six Months | $850,842 | $713,982 | Adjusted Compensation and Benefits Expense Ratio | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :---- | :---- | | Three Months | 53.0% | 55.2% | | Six Months | 55.1% | 57.2% | [Adjusted General and Administrative Expense and Adjusted General and Administrative Expense Ratio](index=37&type=section&id=Adjusted%20General%20and%20Administrative%20Expense%20and%20Adjusted%20General%20and%20Administrative%20Expense%20Ratio) Adjusted general and administrative expense increased, and the adjusted ratio also increased, indicating a higher proportion of administrative costs - Adjusted general and administrative expense excludes acquisition and restructuring general and administrative related expense and other exceptional items[259](index=259&type=chunk) Adjusted General and Administrative Expense (in thousands) | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :-------- | :-------- | | Three Months | $93,350 | $63,790 | | Six Months | $185,587 | $128,592 | Adjusted General and Administrative Expense Ratio | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :---- | :---- | | Three Months | 10.9% | 9.2% | | Six Months | 12.0% | 10.3% | [Adjusted EBITDAC and Adjusted EBITDAC Margin](index=37&type=section&id=Adjusted%20EBITDAC%20and%20Adjusted%20EBITDAC%20Margin) Adjusted EBITDAC increased for both the three and six-month periods, with the margin also showing slight improvement - Adjusted EBITDAC is Net income before Interest expense, net, Income tax expense, Depreciation, Amortization, and Change in contingent consideration, adjusted for certain non-recurring items[261](index=261&type=chunk) Adjusted EBITDAC (in thousands) | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :-------- | :-------- | | Three Months | $308,406 | $247,691 | | Six Months | $508,907 | $404,913 | Adjusted EBITDAC Margin | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :---- | :---- | | Three Months | 36.1% | 35.6% | | Six Months | 32.9% | 32.5% | [Adjusted Net Income and Adjusted Net Income Margin](index=38&type=section&id=Adjusted%20Net%20Income%20and%20Adjusted%20Net%20Income%20Margin) Adjusted net income increased for both periods, while the adjusted net income margin decreased - Adjusted net income is tax-effected earnings before amortization and certain non-recurring items, assuming 100% ownership of the LLC[265](index=265&type=chunk)[266](index=266&type=chunk) Adjusted Net Income (in thousands) | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :-------- | :-------- | | Three Months | $184,682 | $160,554 | | Six Months | $292,521 | $255,971 | Adjusted Net Income Margin | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :---- | :---- | | Three Months | 21.6% | 23.1% | | Six Months | 18.9% | 20.5% | [Adjusted Diluted Earnings Per Share](index=39&type=section&id=Adjusted%20Diluted%20Earnings%20Per%20Share) Adjusted diluted earnings per share increased for both the three and six-month periods - Adjusted diluted earnings per share is calculated by dividing Adjusted net income by diluted shares outstanding, adjusted for the effect of 100% exchange of LLC Common Units and equity awards[270](index=270&type=chunk) Adjusted Diluted Earnings Per Share | Period (Ended June 30) | 2025 | 2024 | | :--------------------- | :---- | :---- | | Three Months | $0.66 | $0.58 | | Six Months | $1.05 | $0.93 | [Liquidity and Capital Resources](index=40&type=section&id=Liquidity%20and%20Capital%20Resources) This section discusses the Company's ability to generate cash flows to meet its business needs, highlighting primary liquidity sources - The Company believes its balance sheet and strong cash flow profile provide adequate liquidity, with primary sources being cash, operating cash flows, and debt capacity[276](index=276&type=chunk) - Fiduciary cash and receivables, totaling **$4,474,847 thousand** as of June 30, 2025, cannot be used for general corporate purposes[25](index=25&type=chunk)[279](index=279&type=chunk)[280](index=280&type=chunk) - The Company expects to have sufficient financial resources to meet its business requirements for the next 12 months and beyond[276](index=276&type=chunk)[281](index=281&type=chunk) [Credit Facilities](index=40&type=section&id=Credit%20Facilities) This sub-section details the Company's debt instruments, including the Term Loan, Senior Secured Notes, and Revolving Credit Facility - The Term Loan principal increased to **$1,700.0 million** in September 2024, with an interest rate of Adjusted Term SOFR + 2.25%[285](index=285&type=chunk) - The Revolving Credit Facility's borrowing capacity increased from **$600.0 million** to **$1,400.0 million** in July 2024, with its maturity extended to July 30, 2029[284](index=284&type=chunk) - The LLC issued **$1,200.0 million** of 5.875% Senior Secured Notes due August 1, 2032, in September and December 2024[286](index=286&type=chunk) [Tax Receivable Agreement](index=41&type=section&id=Tax%20Receivable%20Agreement) This sub-section explains the Tax Receivable Agreement (TRA), under which the Company pays 85% of realized tax savings to LLC Unitholders - The Tax Receivable Agreement (TRA) obligates the Company to pay **85%** of net cash savings in U.S income taxes to current and certain former LLC Unitholders[288](index=288&type=chunk) - As of June 30, 2025, estimated future payments under the TRA total **$461.1 million**, which the Company expects to fund with tax distributions from the LLC[289](index=289&type=chunk)[290](index=290&type=chunk) Tax Receivable Agreement Liabilities (in thousands) | Item | June 30, 2025 | December 31, 2024 | | :-------------------- | :------------ | :---------------- | | TRA Liabilities | $461,112 | $436,296 | | Exchange Tax Attributes | $271,094 | $253,233 | | Pre-IPO M&A Tax Attributes | $84,591 | $83,415 | | TRA Payment Tax Attributes | $105,427 | $99,648 | [Comparison of Cash Flows for the Six Months Ended June 30, 2025 and 2024](index=41&type=section&id=Comparison%20of%20Cash%20Flows%20for%20the%20Six%20Months%20Ended%20June%2030%2C%202025%20and%202024) This sub-section compares the Company's cash flow activities for H1 2025 and H1 2024 - Cash flows from operating activities increased by **$56.5 million** to **$210.8 million** in 2025, driven by higher deferred income tax expense and increased amortization[291](index=291&type=chunk) - Cash flows used in investing activities increased by **$382.3 million** to **$619.0 million** in 2025, primarily due to **$565.1 million** spent on business combinations[292](index=292&type=chunk) - Cash flows provided by financing activities increased by **$162.2 million** to **$234.4 million** in 2025, largely due to **$187.7 million** in net borrowings on the Revolving Credit Facility[293](index=293&type=chunk) [Contractual Obligations and Commitments](index=42&type=section&id=Contractual%20Obligations%20and%20Commitments) This sub-section outlines the Company's principal commitments, including long-term incentive compensation and contingent consideration Long-term Incentive Compensation Agreements (in thousands) | Item | June 30, 2025 | | :------------------------ | :------------ | | Total liability | $32,368 | | Projected future expense | $35,510 | | Total projected future cash outflows | $67,878 | Contingent Consideration (in thousands) | Item | June 30, 2025 | | :------------------------ | :------------ | | Total liability | $114,627 | | Projected future expense | $13,842 | | Total projected future cash outflows | $128,469 | - Projected future cash outflows for long-term incentive compensation are highest in 2028 (**$35,591 thousand**), while for contingent consideration, they are highest in 2027 (**$80,364 thousand**)[298](index=298&type=chunk)[299](index=299&type=chunk) [Critical Accounting Policies](index=43&type=section&id=Critical%20Accounting%20Policies) This section refers to the Company's Annual Report on Form 10-K for a detailed description of its critical accounting policies - Critical accounting policies are described in the Annual Report on Form 10-K for the year ended December 31, 2024[301](index=301&type=chunk) - These policies involve significant estimates, judgments, and assumptions, where changes could materially impact financial position and reported results[300](index=300&type=chunk) - Key critical accounting policies include revenue recognition, business combinations, goodwill and intangibles, income taxes, and tax receivable agreement liabilities[300](index=300&type=chunk) [Recent Accounting Pronouncements](index=43&type=section&id=Recent%20Accounting%20Pronouncements) This section directs readers to Note 1, 'Basis of Presentation,' for information on recently adopted and issued accounting standards - Information on recently adopted accounting pronouncements and recently issued accounting standards not yet adopted is provided in Note 1, 'Basis of Presentation,' to the unaudited consolidated financial statements[303](index=303&type=chunk) [ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK](index=43&type=section&id=ITEM%203.%20QUANTITATIVE%20AND%20QUALITATIVE%20DISCLOSURE%20ABOUT%20MARKET%20RISK) This item discusses the Company's exposure to various market risks, specifically foreign currency risk and interest rate risk [Foreign Currency Risk](index=43&type=section&id=Foreign%20Currency%20Risk) This sub-section addresses the Company's exposure to foreign currency fluctuations, which is deemed immaterial - Approximately **6%** of the Company's revenues for the six months ended June 30, 2025, were generated from international activities[306](index=306&type=chunk) - The Company is exposed to currency risk from potential changes between the exchange rates of the US Dollar, British Pound, Euro, and other currencies[306](index=306&type=chunk) - The exposure to foreign currency risk from changes between the USD and other currencies is considered immaterial[306](index=306&type=chunk) [Interest Rate Risk and Credit Risk](index=43&type=section&id=Interest%20Rate%20Risk%20and%20Credit%20Risk) This sub-section details the Company's exposure to interest rate changes on its floating-rate debt and cash holdings - The Company's Term Loan, with **$1,691.5 million** outstanding principal as of June 30, 2025, bears interest at a floating rate, exposing it to interest rate changes[309](index=309&type=chunk) - An interest rate cap agreement with a **$1,000.0 million** notional amount and **2.75%** strike is used to manage interest rate fluctuations[310](index=310&type=chunk) Impact of Hypothetical 100 BPS Interest Rate Change (June 30, 2025, in thousands) | Item | 100 BPS Increase | 100 BPS Decrease | | :------------------------------------ | :--------------- | :--------------- | | Net exposure to Interest expense, net | $5,189 | $(5,189) | | Net exposure to Fiduciary investment income | $13,462 | $(13,462) | | **Impact to Net income** | **$8,273** | **$(8,273)** | [ITEM 4. CONTROLS AND PROCEDURES](index=44&type=section&id=ITEM%204.%20CONTROLS%20AND%20PROCEDURES) This item addresses the effectiveness of the Company's disclosure controls and procedures and internal control over financial reporting [Evaluation of Disclosure Controls and Procedures](index=44&type=section&id=Evaluation%20of%20Disclosure%20Controls%20and%20Procedures) The Company's principal executive and financial officers concluded that its disclosure controls and procedures were effective as of June 30, 2025 - As of June 30, 2025, the Company's principal executive officer and principal financial officer concluded that its disclosure controls and procedures were effective at the reasonable assurance level[316](index=316&type=chunk) - Disclosure controls and procedures are designed to provide reasonable assurance that information required for SEC reports is recorded, processed, summarized, and reported timely[316](index=316&type=chunk) [Changes in Internal Control](index=44&type=section&id=Changes%20in%20Internal%20Control) There have been no material changes in the Company's internal control over financial reporting during the quarter ended June 30, 2025 - There have been no changes in internal control over financial reporting during the quarter ended June 30, 2025, that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting[318](index=318&type=chunk) [Inherent Limitations of Internal Control Over Financial Reporting](index=44&type=section&id=Inherent%20Limitations%20of%20Internal%20Control%20Over%20Financial%20Reporting) This sub-section acknowledges that no control system can prevent or detect all errors and fraud - Disclosure controls and procedures are designed to provide reasonable assurance, but management does not expect them to prevent or detect all errors and fraud[319](index=319&type=chunk) - Any control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that its objectives will be met[319](index=319&type=chunk) [PART II. OTHER INFORMATION](index=44&type=section&id=PART%20II.%20OTHER%20INFORMATION) This part contains other required disclosures, including legal proceedings, risk factors, and exhibits [ITEM 1. LEGAL PROCEEDINGS](index=44&type=section&id=ITEM%201.%20LEGAL%20PROCEEDINGS) The Company is involved in various legal proceedings but does not believe the outcome would have a material adverse effect - The Company is involved in various legal proceedings and claims that arise in the ordinary course of business[321](index=321&type=chunk) - Management does not believe that the outcome of any current litigation would individually or collectively have a material adverse effect on the Company's business, operating results, cash flows, or financial condition[321](index=321&type=chunk) [ITEM 1A. RISK FACTORS](index=44&type=section&id=ITEM%201A.%20RISK%20FACTORS) This item states that there have been no material changes to the risk factors previously disclosed in the Company's Annual Report - There have been no material changes to the risk factors disclosed under the heading 'Risk Factors' in the Company's Annual Report on Form 10-K for the year ended December 31, 2024[322](index=322&type=chunk) [ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS](index=44&type=section&id=ITEM%202.%20UNREGISTERED%20SALES%20OF%20EQUITY%20SECURITIES%20AND%20USE%20OF%20PROCEEDS) This item indicates that there were no unregistered sales of equity securities or use of proceeds to report - There were no unregistered sales of equity securities and use of proceeds to report[323](index=323&type=chunk) [ITEM 3. DEFAULTS UPON SENIOR SECURITIES](index=44&type=section&id=ITEM%203.%20DEFAULTS%20UPON%20SENIOR%20SECURITIES) This item indicates that there were no defaults upon senior securities to report - There were no defaults upon senior securities to report[323](index=323&type=chunk) [ITEM 4. MINE SAFETY DISCLOSURES](index=44&type=section&id=ITEM%204.%20MINE%20SAFETY%20DISCLOSURES) This item states that mine safety disclosures are not applicable to the Company - Mine safety disclosures are not applicable to the Company[324](index=324&type=chunk) [ITEM 5. OTHER INFORMATION](index=44&type=section&id=ITEM%205.%20OTHER%20INFORMATION) This item indicates that there is no other information to report - There is no other information to report[324](index=324&type=chunk) [ITEM 6. EXHIBITS](index=45&type=section&id=ITEM%206.%20EXHIBITS) This item provides a list of exhibits filed as part of the Form 10-Q, including corporate governance and financial agreement documents - The exhibits include the Amended and Restated Certificate of Incorporation and Bylaws of Ryan Specialty Holdings, Inc[325](index=325&type=chunk) - Indentures for the 4.375% Senior Secured Notes due 2030 and 5.875% Senior Secured Notes due 2032 are filed as exhibits[325](index=325&type=chunk) - Other key exhibits include the Amended and Restated Tax Receivable Agreement, the Seventh Amendment to the Credit Agreement, and various equity incentive plan documents[325](index=325&type=chunk)[326](index=326&type=chunk) [SIGNATURES](index=46&type=section&id=SIGNATURES) This section contains the required signatures for the Form 10-Q, certifying its submission on behalf of the Company - The report is signed by Janice M Hamilton, Executive Vice President and Chief Financial Officer of Ryan Specialty Holdings, Inc[330](index=330&type=chunk) - The signing date for the report is July 31, 2025[330](index=330&type=chunk)

Group 1 - Ryan Specialty Group reported quarterly earnings of $0.66 per share, matching the Zacks Consensus Estimate, and showing an increase from $0.58 per share a year ago [1] - The company posted revenues of $855.17 million for the quarter ended June 2025, exceeding the Zacks Consensus Estimate by 1.46%, and up from $695.44 million year-over-year [2] - Ryan Specialty has topped consensus revenue estimates three times over the last four quarters [2] Group 2 - The stock has underperformed, losing about 6.2% since the beginning of the year, while the S&P 500 has gained 8.2% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters [4] - The current consensus EPS estimate for the coming quarter is $0.49 on revenues of $745.75 million, and for the current fiscal year, it is $2.07 on revenues of $3.08 billion [7] Group 3 - The Zacks Industry Rank for Insurance - Brokerage is in the top 33% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The estimate revisions trend for Ryan Specialty was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock [6]

Financial Data and Key Metrics Changes - Total revenue grew by 23% year-over-year to $855 million, driven by organic revenue growth of 7.1% and M&A contributions adding 13 percentage points to the top line [3][29] - Adjusted EBITDAC increased by 24.5% to $308 million, with an adjusted EBITDAC margin expanding by 50 basis points to 36.1% [3][29] - Adjusted earnings per share rose by 13.8% to $0.66, with an adjusted effective tax rate of 26% for the quarter [29][30] Business Line Data and Key Metrics Changes - The wholesale brokerage specialty performed well, particularly in casualty, with strong new business and high renewal retention [12][15] - Property pricing saw a rapid decline, especially in June, leading to expectations of a modest decline in the property book for the full year [13][31] - The casualty practice experienced excellent growth, particularly in areas such as transportation, public entities, and healthcare, contributing significantly to overall growth [15][16] Market Data and Key Metrics Changes - The property market is facing significant headwinds due to declining pricing, with average reductions of 20% to 30% noted in June [40][66] - Despite the challenges in property, the flow of business into the specialty and E&S market remained strong, supporting overall growth [21][66] - The company anticipates that elevated catastrophe losses will sustain the need for E&S property solutions in the long term [14][15] Company Strategy and Development Direction - The company is focused on expanding its total addressable market through strategic M&A, enhancing capabilities, and broadening its international footprint [6][24] - Investments in key talent and new initiatives are expected to drive growth in the near, medium, and long term, with a goal of achieving double-digit organic growth [6][9] - The strategic alliance with Nationwide Mutual is being renewed, with expectations for significant growth in alternative risk offerings [26][28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating current headwinds and emphasized the importance of strong casualty performance to offset property pricing declines [11][41] - The outlook for casualty lines remains optimistic, with expectations for continued growth driven by firming in niche markets [17][71] - Management acknowledged macroeconomic uncertainties impacting construction but remains committed to long-term growth targets [31][34] Other Important Information - The company closed three acquisitions recently, including JM Wilson, which is expected to enhance its binding authority and transportation offerings [22][24] - The M&A pipeline remains robust, with a focus on strategic, accretive opportunities that align with the company's growth strategy [22][90] - The company is targeting a 35% margin by 2027, supported by its differentiated business model and strong relationships with trading partners [34][46] Q&A Session Summary Question: Insights on property pricing declines in June - Management noted a rapid decline in property pricing, with expectations that these trends will continue for the remainder of the year, leading to a modest decline in the property book [39][66] Question: Impact of investments on margins - The tightening of margins is attributed to property pricing declines and investments in talent for initiatives like Ryan Re, with no specific dollar value provided for these investments [42][44] Question: Outlook for casualty lines - Management remains bullish on casualty lines, expecting continued growth despite property market challenges, with strong performance noted in various niches [71][97] Question: Revenue benefits from the Nationwide deal - While specific revenue figures were not disclosed, management expressed confidence in the growth potential from the Nationwide partnership, particularly in reinsurance underwriting [54][56] Question: M&A environment and future cash flow utilization - The M&A pipeline is strong, and management is optimistic about using free cash flow for future acquisitions while maintaining prudent leverage [86][90]

Company Overview - Ryan Specialty is a rapidly growing provider of specialty products and solutions for insurance brokers, agents, and carriers[8] - The company's total revenue for the Last Twelve Months (LTM) ending June 30, 2025, was $2.8 billion[9] - As of June 30, 2025, Ryan Specialty's year-to-date (YTD) total revenue growth was 23.9%[9] - The YTD organic revenue growth was 9.6%[9] - Ryan Specialty is the 2nd largest U S P&C wholesale broker/managing underwriter[9] Market Position and Growth Strategy - Approximately 78% of Ryan Specialty's premiums are placed in the attractive Excess & Surplus (E&S) market[14] - Ryan Specialty's revenue growth with the top 100 retail brokerage firms exceeded the company's organic revenue growth of 12.8% in 2024[36] - The company has completed 62 acquisitions since its founding[35] - Ryan Specialty is capitalizing on market needs to enhance product capabilities through the launch of new Managing General Underwriters (MGUs) and Programs[38] Financial Performance - Ryan Specialty's LTM Adjusted EBITDAC as of June 30, 2025, was $915 million[52] - As of March 31, 2025, the company had $172 million in unrestricted cash and cash equivalents[59] - As of June 30, 2025, Ryan Specialty's net leverage on a credit basis was 3 5x[60]

[Second Quarter 2025 Results Overview](index=1&type=section&id=Second%20Quarter%202025%20Results%20Overview) Ryan Specialty reported strong financial results for Q2 2025, driven by robust revenue growth and strategic acquisitions [Key Financial Highlights](index=1&type=section&id=Key%20Financial%20Highlights) Ryan Specialty achieved robust financial performance in Q2 2025, with total revenue up 23.0% to $855.2 million, Adjusted EBITDAC up 24.5% to $308.4 million, and Adjusted Diluted EPS up 13.8% to $0.66 | Metric | Q2 2025 | Y-o-Y Growth | Q2 2024 | | :-------------------------------- | :--------------- | :------- | :--------------- | | **Total Revenue** | $855.2 million USD | 23.0% | $695.4 million USD | | **Organic Revenue Growth Rate** | 7.1% | - | 14.2% | | **Net Income** | $124.7 million USD | 5.6% | $118.0 million USD | | **Diluted EPS** | $0.38 | - | - | | **Adjusted EBITDAC** | $308.4 million USD | 24.5% | $247.7 million USD | | **Adjusted EBITDAC Margin** | 36.1% | - | 35.6% | | **Adjusted Net Income** | $184.7 million USD | 15.0% | $160.6 million USD | | **Adjusted Diluted EPS** | $0.66 | 13.8% | $0.58 | | **Capital Returned to Shareholders** | $21.9 million USD | - | - | [Management Commentary](index=1&type=section&id=Management%20Commentary) Management highlighted robust performance despite challenging property rate environments and high comparables, driven by recent M&A and strong organic growth, further solidifying leadership in delegated underwriting through strategic alliances and acquisitions - The company achieved **23% total revenue growth** and **24.5% Adjusted EBITDAC growth** amidst a rapidly declining property rate environment and challenging year-over-year comparisons, highlighting the resilience of its differentiated platform[3](index=3&type=chunk) - Management noted recent M&A and organic growth in a difficult climate contributed significantly to performance, successfully completing three acquisitions to further solidify the company's leadership in delegated underwriting[3](index=3&type=chunk) - The company is expanding strategic carrier alliances, expected to significantly enhance its ability to generate new business, and remains committed to achieving its full-year double-digit organic growth target[3](index=3&type=chunk) [Second Quarter 2025 Financial Review](index=2&type=section&id=Second%20Quarter%202025%20Financial%20Review) This section provides a detailed financial review of Q2 2025, covering revenue, operating expenses, net income, and adjusted earnings metrics [Total Revenue Performance](index=2&type=section&id=Total%20Revenue%20Performance) Total revenue reached $855.2 million in Q2 2025, a 23.0% year-over-year increase, driven by 7.1% organic growth, new client acquisition, expanded client relationships, E&S market expansion, recent acquisitions, contingent commission changes, and foreign exchange impacts, with casualty growth offsetting a slight property decline | Metric | Q2 2025 | Q2 2024 | Change ($) | Change (%) | | :---------------- | :--------------- | :--------------- | :------- | :------- | | **Total Revenue** | $855,170 | $695,441 | $159,729 | 23.0% | | **Net Commissions and Fees** | $840,857 | $680,248 | $160,609 | 23.6% | - Revenue growth was primarily driven by **7.1% organic revenue growth**, benefiting from successful new client acquisition, deepened existing client relationships, and continued expansion in the E&S market[7](index=7&type=chunk) - Recently completed acquisitions, changes in contingent commissions, and favorable foreign exchange rates also contributed positively to total revenue growth[7](index=7&type=chunk) [Operating Expenses Analysis](index=2&type=section&id=Operating%20Expenses%20Analysis) Total operating expenses in Q2 2025 increased 25.1% to $664.1 million, primarily due to higher compensation and benefits from headcount and revenue growth, acquisition-related costs, long-term incentive compensation, IT, professional services, travel, entertainment, and foreign exchange, partially offset by reduced restructuring expenses from the ACCELERATE 2025 program completion | Metric | Q2 2025 | Q2 2024 | Change ($) | Change (%) | | :--------------------- | :--------------- | :--------------- | :------- | :------- | | **Total Operating Expenses** | $664,118 | $531,073 | $133,045 | 25.1% | | **Compensation and Benefits** | $485,272 | $414,049 | $71,223 | 17.2% | | **General and Administrative Expenses** | $107,049 | $82,967 | $24,082 | 29.0% | - Compensation and benefits expense increased due to higher compensation from headcount and revenue growth, as well as acquisition-related expenses and increased long-term incentive compensation[8](index=8&type=chunk)[9](index=9&type=chunk) - General and administrative expenses increased due to higher IT and professional services, travel and entertainment, and foreign exchange expenses, partially offset by reduced restructuring-related costs from the completion of the ACCELERATE 2025 program[9](index=9&type=chunk) [Net Income and Adjusted EBITDAC Performance](index=3&type=section&id=Net%20Income%20and%20Adjusted%20EBITDAC%20Performance) Net income grew 5.6% to $124.7 million in Q2 2025, driven by strong revenue and lower income tax expense, partially offset by higher operating expenses and interest; Adjusted EBITDAC increased 24.5% to $308.4 million, with margin rising to 36.1%, primarily due to robust revenue growth | Metric | Q2 2025 | Q2 2024 | Change ($) | Change (%) | | :-------------------- | :--------------- | :--------------- | :------- | :------- | | **Net Income** | $124,705 | $118,038 | $6,667 | 5.6% | | **Adjusted EBITDAC** | $308,406 | $247,691 | $60,715 | 24.5% | | **Adjusted EBITDAC Margin** | 36.1% | 35.6% | - | - | - Net income growth was primarily attributable to strong revenue growth and lower income tax expense, partially offset by higher total operating expenses and net interest expense[10](index=10&type=chunk) - Adjusted EBITDAC growth was primarily driven by strong revenue growth, partially offset by higher adjusted compensation and benefits expense and adjusted general and administrative expenses[11](index=11&type=chunk) [Adjusted Net Income and Diluted EPS Performance](index=3&type=section&id=Adjusted%20Net%20Income%20and%20Diluted%20EPS%20Performance) Adjusted net income increased 15.0% to $184.7 million in Q2 2025, with Adjusted Diluted EPS up 13.8% to $0.66; overall profitability grew despite a slight decrease in Adjusted Net Income Margin | Metric | Q2 2025 | Q2 2024 | Change ($) | Change (%) | | :------------------------- | :--------------- | :--------------- | :------- | :------- | | **Adjusted Net Income** | $184,682 | $160,554 | $24,128 | 15.0% | | **Adjusted Net Income Margin** | 21.6% | 23.1% | - | - | | **Adjusted Diluted EPS** | $0.66 | $0.58 | $0.08 | 13.8% | [Net Commissions and Fees Breakdown](index=3&type=section&id=Net%20Commissions%20and%20Fees%20Breakdown) This section details net commissions and fees by specialty and type, highlighting growth across all segments [Net Commissions and Fees by Specialty](index=3&type=section&id=Net%20Commissions%20and%20Fees%20by%20Specialty) In Q2 2025, net commissions and fees grew across all specialty segments, with Underwriting Management notably up 73.1% to $269.2 million, and Wholesale Brokerage and Delegated Underwriting growing 7.4% and 17.2% respectively | Specialty Segment | Q2 2025 (thousand USD) | Q2 2025 (%) | Q2 2024 (thousand USD) | Q2 2024 (%) | Change (thousand USD) | Change (%) | | :--------------- | :------------------- | :----------------- | :------------------- | :----------------- | :---------- | :------- | | **Wholesale Brokerage** | 477,165 | 56.7% | 444,129 | 65.3% | 33,036 | 7.4% | | **Delegated Underwriting** | 94,524 | 11.2% | 80,630 | 11.8% | 13,894 | 17.2% | | **Underwriting Management** | 269,168 | 32.1% | 155,489 | 22.9% | 113,679 | 73.1% | | **Total Net Commissions and Fees** | 840,857 | | 680,248 | | 160,609 | 23.6% | - Net commissions and fees growth across all specialty segments was primarily driven by robust organic growth[14](index=14&type=chunk) [Revenue by Type of Commission and Fees](index=4&type=section&id=Revenue%20by%20Type%20of%20Commission%20and%20Fees) Net commissions and policy fees remained the primary revenue source in Q2 2025, growing 19.8%; notably, supplemental and contingent commissions surged 299.1% year-over-year to $35.63 million | Commission and Fee Type | Q2 2025 (thousand USD) | Q2 2025 (%) | Q2 2024 (thousand USD) | Q2 2024 (%) | Change (thousand USD) | Change (%) | | :----------------------- | :------------------- | :----------------- | :------------------- | :----------------- | :---------- | :------- | | **Net Commissions and Policy Fees** | 787,074 | 93.6% | 656,938 | 96.6% | 130,136 | 19.8% | | **Supplemental and Contingent Commissions** | 35,630 | 4.2% | 8,927 | 1.3% | 26,703 | 299.1% | | **Loss Mitigation and Other Fees** | 18,153 | 2.2% | 14,383 | 2.1% | 3,770 | 26.2% | | **Total Net Commissions and Fees** | 840,857 | | 680,248 | | 160,609 | 23.6% | [Liquidity and Capital Management](index=4&type=section&id=Liquidity%20and%20Capital%20Management) The company's liquidity position and capital management strategies are reviewed, including cash, debt, and dividend declarations [Liquidity and Financial Condition](index=4&type=section&id=Liquidity%20and%20Financial%20Condition) As of June 30, 2025, the company held $172.6 million in cash and cash equivalents and had $3.5 billion in outstanding debt principal | Metric | As of June 30, 2025 ($) | | :------------------- | :---------------- | | **Cash and Cash Equivalents** | 172.6 million USD | | **Outstanding Debt Principal** | 3.5 billion USD | [Quarterly Dividend Declaration](index=4&type=section&id=Quarterly%20Dividend%20Declaration) The Board declared a quarterly dividend of $0.12 per share for Class A common stock on July 31, 2025, payable August 26, 2025, to shareholders of record on August 12, 2025, with $0.05 per share funded by Ryan Specialty, LLC's free cash flow - The Board declared a quarterly dividend of **$0.12 per share**, with **$0.05 per share** funded by Ryan Specialty, LLC's free cash flow[19](index=19&type=chunk) - The dividend will be paid on August 26, 2025, to Class A common stockholders and LLC common unit holders of record as of the close of business on August 12, 2025[19](index=19&type=chunk) [Full Year 2025 Outlook](index=4&type=section&id=Full%20Year%202025%20Outlook) The company updated its full-year 2025 guidance, lowering organic revenue growth expectations to 9.0%–11.0% and adjusting Adjusted EBITDAC margin to 32.5%–33.0% | Metric | New Guidance (Full Year 2025) | Original Guidance (Full Year 2025) | | :---------------------- | :------------------ | :------------------ | | **Organic Revenue Growth Rate** | 9.0% – 11.0% | 11.0% – 13.0% | | **Adjusted EBITDAC Margin** | 32.5% – 33.0% | 32.5% – 33.5% | - The company cannot provide a comparable outlook or reconciliation for total revenue growth rate or net income margin due to the inherent difficulty in forecasting certain reconciling items, such as effective tax rates, acquisition activity expenses, and one-time items[20](index=20&type=chunk) [Company Information](index=5&type=section&id=Company%20Information) This section provides essential company information, including conference call details, company overview, and forward-looking statements [Conference Call Details](index=5&type=section&id=Conference%20Call%20Details) Ryan Specialty will host a conference call on July 31, 2025, at 4:45 PM ET to discuss financial results, accessible via webcast or the company's investor relations website - The conference call will be held on July 31, 2025, at **4:45 PM ET** to discuss financial results[22](index=22&type=chunk) - A webcast replay will be available for one year on the investor section of the company's website[23](index=23&type=chunk) [About Ryan Specialty](index=5&type=section&id=About%20Ryan%20Specialty) Founded in 2010, Ryan Specialty is a leading provider of specialty insurance products and services, offering distribution, underwriting, product development, administration, and risk management to brokers, agents, and carriers through wholesale brokerage and delegated underwriting manager roles - Ryan Specialty, founded in 2010, is a service provider offering specialty products and solutions to insurance brokers, agents, and carriers[24](index=24&type=chunk) - The company provides distribution, underwriting, product development, administration, and risk management services through its wholesale brokerage and delegated underwriting manager roles for insurance carriers[24](index=24&type=chunk) [Forward-Looking Statements](index=5&type=section&id=Forward-Looking%20Statements) All non-historical statements in this report are 'forward-looking statements' under the Private Securities Litigation Reform Act of 1995, involving significant risks and uncertainties; investors are cautioned not to place undue reliance, as actual results may differ materially from expectations - All statements regarding estimated costs, expenditures, cash flows, growth rates, and financial results, as well as plans and objectives for future operations, growth plans, or strategies, are forward-looking statements[25](index=25&type=chunk) - Forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from the company's expectations[26](index=26&type=chunk) - The company undertakes no obligation to publicly update any forward-looking statements and cautions investors not to place undue reliance on these statements or view past financial performance as a reliable indicator of future performance[27](index=27&type=chunk) [Non-GAAP Financial Measures and Key Performance Indicators](index=6&type=section&id=Non-GAAP%20Financial%20Measures%20and%20Key%20Performance%20Indicators) This section defines the non-GAAP financial measures and key performance indicators used to assess the company's business performance [Definitions of Non-GAAP Measures](index=6&type=section&id=Definitions%20of%20Non-GAAP%20Measures) This section defines non-GAAP financial measures used to assess business performance, including organic revenue growth rate, adjusted compensation and benefits expense, adjusted general and administrative expenses, adjusted EBITDAC, adjusted net income, adjusted diluted EPS, and credit adjusted EBITDAC, emphasizing their supplementary role to GAAP financials - Non-GAAP financial measures are used by management and investors to assess operating performance by excluding potential differences from capital structure, taxes, depreciation, amortization, and certain other items not representative of core business[28](index=28&type=chunk) - Organic revenue growth rate measures the percentage change in net commissions and fees, adjusted for acquisitions, dispositions, contingent commissions, and foreign exchange impacts[30](index=30&type=chunk) - Adjusted EBITDAC is defined as net income, adjusted for interest expense, income tax expense, depreciation, amortization, and changes in contingent consideration, further adjusted for equity-based compensation, acquisition-related expenses, and other non-recurring items[34](index=34&type=chunk) [Unaudited Consolidated Financial Statements](index=8&type=section&id=Unaudited%20Consolidated%20Financial%20Statements) This section presents the unaudited consolidated financial statements, including income statements, balance sheets, and cash flow statements [Consolidated Statements of Income](index=8&type=section&id=Consolidated%20Statements%20of%20Income) This section presents Ryan Specialty's unaudited consolidated statements of income, detailing key financial data such as revenue, expenses, net income, and EPS for Q2 and H1 2025 and 2024 | (thousand USD, except per share data) | Q2 2025 | Q2 2024 | H1 2025 | H1 2024 | | :----------------------- | :--------------- | :--------------- | :----------- | :----------- | | **Total Revenue** | $855,170 | $695,441 | $1,545,336 | $1,247,487 | | **Total Operating Expenses** | $664,118 | $531,073 | $1,254,049 | $1,010,470 | | **Operating Income** | $191,052 | $164,368 | $291,287 | $237,017 | | **Net Income** | $124,705 | $118,038 | $120,316 | $158,715 | | **Diluted EPS** | $0.38 | $0.37 | $0.18 | $0.49 | [Consolidated Balance Sheets](index=9&type=section&id=Consolidated%20Balance%20Sheets) This section presents Ryan Specialty's unaudited consolidated balance sheets as of June 30, 2025, and December 31, 2024, detailing the company's assets, liabilities, and stockholders' equity | (thousand USD) | As of June 30, 2025 | As of Dec 31, 2024 | | :----------------------- | :------------- | :------------- | | **Total Assets** | $10,625,772 | $9,649,918 | | **Total Liabilities** | $9,443,623 | $8,551,633 | | **Total Stockholders' Equity** | $1,182,149 | $1,098,285 | | **Cash and Cash Equivalents** | $172,589 | $540,203 | | **Goodwill** | $3,085,182 | $2,646,676 | [Consolidated Statements of Cash Flows](index=10&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) This section provides Ryan Specialty's unaudited consolidated statements of cash flows for the six months ended June 30, 2025, and 2024, covering operating, investing, and financing activities | (thousand USD) | H1 2025 | H1 2024 | | :------------------------- | :----------- | :----------- | | **Net Cash Provided by Operating Activities** | $210,760 | $154,288 | | **Net Cash Used in Investing Activities** | ($618,980) | ($236,698) | | **Net Cash Provided by Financing Activities** | $234,370 | $72,191 | | **Cash and Cash Equivalents, End of Period** | $1,518,762 | $1,744,103 | - Net cash used in investing activities was primarily impacted by business combinations (net of cash), totaling **$565.1 million** in H1 2025, significantly higher than **$214.1 million** in H1 2024[48](index=48&type=chunk) [Reconciliation of Non-GAAP Financial Measures](index=10&type=section&id=Reconciliation%20of%20Non-GAAP%20Financial%20Measures) This section provides detailed reconciliations of non-GAAP financial measures to their most directly comparable GAAP measures [Organic Revenue Growth Rate Reconciliation](index=10&type=section&id=Organic%20Revenue%20Growth%20Rate%20Reconciliation) This section provides a detailed reconciliation of organic revenue growth rate, showing Q2 2025 organic revenue growth at 7.1%, down from 14.2% in the prior year, with adjustments for contingent commissions, revenue from sold businesses, M&A, and foreign exchange impacts | (thousand USD, except percentages) | Q2 2025 | Q2 2024 | | :---------------------------------------------------------------- | :--------------- | :--------------- | | **Current Period Net Commissions and Fees Revenue** | $840,857 | $680,248 | | **Less: Current Period Contingent Commissions** | ($27,392) | ($5,396) | | **Less: Revenue from Businesses Sold** | ($144) | — | | **Net Commissions and Fees Revenue (Excluding Contingent Commissions)** | $813,321 | $674,852 | | **Organic Revenue Growth (Non-GAAP)** | $48,429 | $80,535 | | **Organic Revenue Growth Rate (Non-GAAP)** | 7.1% | 14.2% | [Adjusted Compensation and Benefits Expense Reconciliation](index=11&type=section&id=Adjusted%20Compensation%20and%20Benefits%20Expense%20Reconciliation) This section reconciles compensation and benefits expense to adjusted compensation and benefits expense, showing Q2 2025 adjusted compensation and benefits expense at $453.4 million, with an adjusted expense ratio of 53.0%, lower than GAAP's 56.7% | (thousand USD, except percentages) | Q2 2025 | Q2 2024 | | :---------------------------------------------------------------- | :--------------- | :--------------- | | **Compensation and Benefits Expense** | $485,272 | $414,049 | | **Acquisition-Related Expenses** | ($1,484) | ($1,160) | | **Acquisition-Related Long-Term Incentive Compensation** | ($9,321) | ($2,891) | | **Restructuring and Related Expenses** | — | ($3,799) | | **Equity-Based Compensation** | ($14,853) | ($12,756) | | **Adjusted Compensation and Benefits Expense** | $453,414 | $383,960 | | **Compensation and Benefits Expense Ratio** | 56.7% | 59.5% | | **Adjusted Compensation and Benefits Expense Ratio** | 53.0% | 55.2% | [Adjusted General and Administrative Expense Reconciliation](index=12&type=section&id=Adjusted%20General%20and%20Administrative%20Expense%20Reconciliation) This section reconciles general and administrative expenses to adjusted general and administrative expenses, showing Q2 2025 adjusted general and administrative expenses at $93.35 million, with an adjusted expense ratio of 10.9%, lower than GAAP's 12.5% | (thousand USD, except percentages) | Q2 2025 | Q2 2024 | | :---------------------------------------------------------------- | :--------------- | :--------------- | | **General and Administrative Expenses** | $107,049 | $82,967 | | **Acquisition-Related Expenses** | ($13,699) | ($15,008) | | **Restructuring and Related Expenses** | — | ($4,169) | | **Adjusted General and Administrative Expenses** | $93,350 | $63,790 | | **General and Administrative Expense Ratio** | 12.5% | 11.9% | | **Adjusted General and Administrative Expense Ratio** | 10.9% | 9.2% | [Adjusted EBITDAC Reconciliation](index=12&type=section&id=Adjusted%20EBITDAC%20Reconciliation) This section reconciles net income to Adjusted EBITDAC, showing Q2 2025 Adjusted EBITDAC at $308.4 million, with an Adjusted EBITDAC margin of 36.1%, higher than 35.6% in the prior year | (thousand USD, except percentages) | Q2 2025 | Q2 2024 | | :---------------------------------------------------------------- | :--------------- | :--------------- | | **Net Income** | $124,705 | $118,038 | | **Interest Expense, Net** | 58,334 | 31,128 | | **Income Tax Expense** | 13,026 | 18,691 | | **Depreciation** | 2,888 | 2,273 | | **Amortization** | 69,668 | 30,541 | | **Change in Contingent Consideration** | (759) | 1,243 | | **EBITDAC** | $267,862 | $201,914 | | **Acquisition-Related Expenses** | 15,183 | 16,168 | | **Equity-Based Compensation** | 14,853 | 12,756 | | **Adjusted EBITDAC** | $308,406 | $247,691 | | **Adjusted EBITDAC Margin** | 36.1% | 35.6% | [Adjusted Net Income Reconciliation](index=13&type=section&id=Adjusted%20Net%20Income%20Reconciliation) This section reconciles net income to Adjusted Net Income, showing Q2 2025 Adjusted Net Income at $184.7 million, with an Adjusted Net Income margin of 21.6%, slightly lower than 23.1% in the prior year | (thousand USD, except percentages) | Q2 2025 | Q2 2024 | | :---------------------------------------------------------------- | :--------------- | :--------------- | | **Net Income** | $124,705 | $118,038 | | **Income Tax Expense** | 13,026 | 18,691 | | **Amortization** | 69,668 | 30,541 | | **Acquisition-Related Expenses** | 15,183 | 16,168 | | **Equity-Based Compensation** | 14,853 | 12,756 | | **Adjusted Pre-Tax Income** | $249,570 | $217,317 | | **Adjusted Income Tax Expense** | ($64,888) | ($56,763) | | **Adjusted Net Income** | $184,682 | $160,554 | | **Adjusted Net Income Margin** | 21.6% | 23.1% | [Adjusted Diluted Earnings per Share Reconciliation](index=14&type=section&id=Adjusted%20Diluted%20Earnings%20per%20Share%20Reconciliation) This section reconciles diluted EPS to Adjusted Diluted EPS, showing Q2 2025 Adjusted Diluted EPS at $0.66, higher than $0.58 in the prior year | (except per share data) | Q2 2025 | Q2 2024 | | :---------------------------------------------------------------- | :--------------- | :--------------- | | **Diluted EPS for Class A Common Stock** | $0.38 | $0.37 | | **Less: Net Income Impact Attributable to Diluted Shares and Substantially Vested RSUs** | ($0.19) | ($0.20) | | **Add: Impact of All LLC Common Units Converted to Class A Shares** | $0.26 | $0.27 | | **Add: Adjustments to Adjusted Net Income** | $0.22 | $0.15 | | **Adjusted Diluted EPS** | $0.66 | $0.58 | [Credit Adjusted EBITDAC Reconciliation](index=15&type=section&id=Credit%20Adjusted%20EBITDAC%20Reconciliation) This section reconciles net income to Credit Adjusted EBITDAC, showing Credit Adjusted EBITDAC for the twelve months ended June 30, 2025, at $956.2 million | (thousand USD) | For the twelve months ended June 30, 2025 | | :---------------------------------------------------------------- | :--------------------------- | | **Net Income** | $191,514 | | **Interest Expense, Net** | 210,762 | | **Income Tax Expense** | 85,980 | | **Depreciation** | 10,959 | | **Amortization** | 233,969 | | **EBITDAC** | $694,346 | | **Acquisition-Related Expenses** | 77,722 | | **Equity-Based Compensation** | 59,189 | | **Adjusted EBITDAC** | $915,217 | | **Credit Adjustment** | 40,991 | | **Credit Adjusted EBITDAC** | $956,208 |

Financial Performance - Ryan Specialty's total revenue for the Last Twelve Months(LTM) ending June 30, 2025, was $2.814 billion[9, 52] - The company's Organic Revenue Growth for the period ending June 30, 2025, was 9.6%[9] - Adjusted EBITDAC for the LTM ending June 30, 2025, reached $915 million, with an Adjusted EBITDAC Margin of 32.5%[54] Market Position and Growth - Ryan Specialty is the 2nd largest U S P&C wholesale broker/managing underwriter[9] - The company experienced a total revenue growth of 23.9% for the period ending June 30, 2025[9] - Ryan Specialty's revenue growth with the top 100 retail brokerage firms exceeded the company's organic revenue growth of 12.8% in 2024[36] Market Dynamics - Excess and Surplus (E&S) premiums are growing faster than the admitted market, with E&S representing 24% of the commercial market[13, 18] - Delegated authority represented 29% of E&S premiums in 2023[36] Strategic Activities - Ryan Specialty has completed 62 acquisitions since its founding[35] - Approximately $115 million of revenue was acquired thus far in 2025[37] - Wholesale Brokerage accounts for 56% of the business, Underwriting Management 31%, and Binding Authority 13%[28]

Core Insights - PepsiCo is launching an exclusive collaboration with streetwear brand Samii Ryan, featuring a capsule collection that combines Y2K nostalgia and rodeo-core fashion with the flavor of PEPSI® Wild Cherry, available online starting July 11, 2025 [1][3] Company Overview - PepsiCo products are consumed over one billion times daily across more than 200 countries, showcasing the company's extensive reach and commitment to innovation in the beverage industry [6] Collaboration Details - The Pepsi® x Samii Ryan collection includes vintage-inspired denim jackets, graphic tees, cozy sweats, and accessories, all featuring cherry red hues and retro PEPSI iconography, emphasizing a playful blend of fashion and flavor [2] - The collaboration was facilitated by Joester Loria Group for PepsiCo and Blitz Licensing for Samii Ryan, indicating a strategic partnership to enhance brand visibility [4] Brand Identity - Samii Ryan, the founder of the eponymous brand, emphasizes that the collaboration reflects joy, energy, and self-expression, aligning with the brand's focus on nostalgic and feel-good fashion inspired by femininity and pop culture [5]

Company Overview - Ryan Specialty Group (RSG) is a rapidly growing provider of specialty products and solutions for insurance brokers, agents, and carriers[11] - RSG was founded in 2010[12] - As of September 30, 2021, RSG's LTM (Last Twelve Months) revenue was $1.4 billion[12] - RSG is the 2nd largest U S P&C wholesale broker[12] Financial Performance - RSG's organic revenue growth for the period ending September 30, 2021, YTD (Year-to-Date) was 25 6%[12] - RSG's LTM total revenue growth as of September 30, 2021, was 51 6%[12] - The Adjusted EBITDAC for LTM was $442 million[49] - The Adjusted EBITDAC Margin was 32 0%[49] Market Position and Growth Strategy - 71% of RSG's premiums are placed in the attractive E&S (Excess & Surplus) market[19] - The E&S market has experienced a CAGR (Compound Annual Growth Rate) of 6 4% compared to the admitted market's CAGR of 4 0% over the past decade[21] - RSG's revenue growth with the top 100 retail brokerage firms exceeded RSG's organic revenue growth of 20% in 2020[31] - RSG has completed over 40 acquisitions since its founding[31]